277 related articles for article (PubMed ID: 35758185)
21. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications.
Rubin MA; de La Taille A; Bagiella E; Olsson CA; O'Toole KM
Am J Surg Pathol; 1998 Jul; 22(7):840-8. PubMed ID: 9669346
[TBL] [Abstract][Full Text] [Related]
22. Prostatic intraepithelial neoplasia: recent advances.
Ayala AG; Ro JY
Arch Pathol Lab Med; 2007 Aug; 131(8):1257-66. PubMed ID: 17683188
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous clinicopathological features of intraductal carcinoma of the prostate: a comparison between "precursor-like" and "regular type" lesions.
Miyai K; Divatia MK; Shen SS; Miles BJ; Ayala AG; Ro JY
Int J Clin Exp Pathol; 2014; 7(5):2518-26. PubMed ID: 24966964
[TBL] [Abstract][Full Text] [Related]
24. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma.
Cohen RJ; Wheeler TM; Bonkhoff H; Rubin MA
Arch Pathol Lab Med; 2007 Jul; 131(7):1103-9. PubMed ID: 17616999
[TBL] [Abstract][Full Text] [Related]
25. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part B: Prostate and Bladder Tumours.
Humphrey PA; Moch H; Cubilla AL; Ulbright TM; Reuter VE
Eur Urol; 2016 Jul; 70(1):106-119. PubMed ID: 26996659
[TBL] [Abstract][Full Text] [Related]
26. Small Cell-like Change in Central Zone Histology-A New Observation Mimicking Cribriform Intraductal Prostatic Adenocarcinoma.
Kryvenko ON
Int J Surg Pathol; 2021 Sep; 29(6):635-637. PubMed ID: 33729852
[TBL] [Abstract][Full Text] [Related]
27. In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 1: Prostatic intraepithelial neoplasia.
Clouston D; Bolton D
BJU Int; 2012 Apr; 109 Suppl 3():22-6. PubMed ID: 22458488
[TBL] [Abstract][Full Text] [Related]
28. Differential Diagnosis of Intraductal Lesions of the Prostate.
Wobker SE; Epstein JI
Am J Surg Pathol; 2016 Jun; 40(6):e67-82. PubMed ID: 26848801
[TBL] [Abstract][Full Text] [Related]
29. Cribriform Lesions of the Prostate Gland.
Cai Q; Shah RB
Surg Pathol Clin; 2022 Dec; 15(4):591-608. PubMed ID: 36344177
[TBL] [Abstract][Full Text] [Related]
30. In situ and intraductal epithelial proliferations of prostate: definitions and treatment implications. Part 2: intraductal carcinoma and ductal adenocarcinoma of prostate.
Clouston D; Bolton D
BJU Int; 2012 Dec; 110 Suppl 4():22-4. PubMed ID: 23194119
[TBL] [Abstract][Full Text] [Related]
31. Rare histological patterns of prostatic ductal adenocarcinoma.
Lee TK; Miller JS; Epstein JI
Pathology; 2010 Jun; 42(4):319-24. PubMed ID: 20438402
[TBL] [Abstract][Full Text] [Related]
32. Premalignancy in Prostate Cancer: Rethinking What we Know.
De Marzo AM; Haffner MC; Lotan TL; Yegnasubramanian S; Nelson WG
Cancer Prev Res (Phila); 2016 Aug; 9(8):648-56. PubMed ID: 26813971
[TBL] [Abstract][Full Text] [Related]
33. Updates of Prostate Cancer from the 2022 World Health Organization Classification of the Urinary and Male Genital Tumors.
Guo CC; Czerniak B
J Clin Transl Pathol; 2023; 3(1):26-34. PubMed ID: 38605939
[TBL] [Abstract][Full Text] [Related]
34. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.
Epstein JI; Amin MB; Fine SW; Algaba F; Aron M; Baydar DE; Beltran AL; Brimo F; Cheville JC; Colecchia M; Comperat E; da Cunha IW; Delprado W; DeMarzo AM; Giannico GA; Gordetsky JB; Guo CC; Hansel DE; Hirsch MS; Huang J; Humphrey PA; Jimenez RE; Khani F; Kong Q; Kryvenko ON; Kunju LP; Lal P; Latour M; Lotan T; Maclean F; Magi-Galluzzi C; Mehra R; Menon S; Miyamoto H; Montironi R; Netto GJ; Nguyen JK; Osunkoya AO; Parwani A; Robinson BD; Rubin MA; Shah RB; So JS; Takahashi H; Tavora F; Tretiakova MS; True L; Wobker SE; Yang XJ; Zhou M; Zynger DL; Trpkov K
Arch Pathol Lab Med; 2021 Apr; 145(4):461-493. PubMed ID: 32589068
[TBL] [Abstract][Full Text] [Related]
35. My approach to intraductal lesions of the prostate gland.
Pickup M; Van der Kwast TH
J Clin Pathol; 2007 Aug; 60(8):856-65. PubMed ID: 17237185
[TBL] [Abstract][Full Text] [Related]
36. Desquamating apoptotic variant of high-grade prostatic intraepithelial neoplasia: a possible precursor of intraductal prostatic carcinoma.
Cohen RJ; O'Brien BA; Wheeler TM
Hum Pathol; 2011 Jun; 42(6):892-5. PubMed ID: 21288556
[TBL] [Abstract][Full Text] [Related]
37. Premalignant and malignant prostate lesions: pathologic review.
Dickinson SI
Cancer Control; 2010 Oct; 17(4):214-22. PubMed ID: 20861809
[TBL] [Abstract][Full Text] [Related]
38. PIN-like ductal carcinoma of the prostate has frequent activating RAS/RAF mutations.
Kaur HB; Salles DC; Paulk A; Epstein JI; Eshleman JR; Lotan TL
Histopathology; 2021 Jan; 78(2):327-333. PubMed ID: 32740981
[TBL] [Abstract][Full Text] [Related]
39. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care.
Epstein JI; Herawi M
J Urol; 2006 Mar; 175(3 Pt 1):820-34. PubMed ID: 16469560
[TBL] [Abstract][Full Text] [Related]
40. Unusual histologic types of high-grade prostatic intraepithelial neoplasia.
Reyes AO; Swanson PE; Carbone JM; Humphrey PA
Am J Surg Pathol; 1997 Oct; 21(10):1215-22. PubMed ID: 9331295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
